Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15, 1068
Text Correction
References
- Pott-Junior, H.; Paoliello, M.M.B.; de Queiroz Constantino Miguel, A.; da Cunha, A.F.; de Melo Freire, C.C.; Neves, F.F.; da Silva de Avó, L.R.; Roscani, M.G.; De Sousa dos Santos, S.; Chach’, S.G.F. Retraction notice to “Use of ivermectin in the treatment of Covid-19: A pilot trial” [toxicol. rep. 8 (2021) 505–510]. Toxicol. Rep. 2022, 9, 1023. [Google Scholar] [CrossRef] [PubMed]
- Awad, H.; Hassan, B.; Dweek, S.; Aboelata, Y.; Rawas-Qalaji, M.; Ahmed, I.S. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15, 1068. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Awad, H.; Hassan, B.; Dweek, S.; Aboelata, Y.; Rawas-Qalaji, M.; Ahmed, I.S. Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15, 1068. Pharmaceuticals 2024, 17, 1100. https://doi.org/10.3390/ph17081100
Awad H, Hassan B, Dweek S, Aboelata Y, Rawas-Qalaji M, Ahmed IS. Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15, 1068. Pharmaceuticals. 2024; 17(8):1100. https://doi.org/10.3390/ph17081100
Chicago/Turabian StyleAwad, Hoda, Basmala Hassan, Sara Dweek, Yasmeen Aboelata, Mutasem Rawas-Qalaji, and Iman Saad Ahmed. 2024. "Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15, 1068" Pharmaceuticals 17, no. 8: 1100. https://doi.org/10.3390/ph17081100